docs / articles / Hydroxychloroquine Eye Exam: Frequency & Timing

Hydroxychloroquine Eye Exam: Frequency & Timing

Sara Jul 09, 2026 2026-07-09 04:40:45

Hydroxychloroquine, a medication commonly used to prevent and treat malaria, has recently garnered attention due to its potential off-label use in managing certain eye conditions. One of the key aspects to consider when using hydroxychloroquine is the frequency of eye examinations. Regular eye checks are crucial to monitor and manage potential side effects, primarily retinal toxicity.

This holidays season, be a hero 🦸‍♀️ and celebrate safely! #COVID19
This holidays season, be a hero 🦸‍♀️ and celebrate safely! #COVID19

Hydroxychloroquine can accumulate in the retina over time, potentially leading to vision loss if not monitored closely. Therefore, it's essential to understand the recommended eye exam frequency for patients taking this medication.

Do it all to protect others and stop #COVID19.
Do it all to protect others and stop #COVID19.

Eye Exam Frequency Guidelines

The American Academy of Ophthalmology (AAO) provides guidelines for hydroxychloroquine eye examinations. These recommendations are based on the duration of treatment and the patient's cumulative dose.

Do it all. Get extra benefits. Stop #COVID19.
Do it all. Get extra benefits. Stop #COVID19.

It's important to note that these guidelines are not one-size-fits-all. Individual patient factors, such as age, pre-existing eye conditions, and other medications, may influence the frequency of eye examinations.

Initial Eye Examination

E - Error
E - Error

Before starting hydroxychloroquine, an initial baseline eye examination is recommended. This exam should include a comprehensive eye health evaluation, including visual acuity, color vision testing, and fundus photography or optical coherence tomography (OCT) of the macula.

This baseline assessment helps establish a reference point to compare future exam results, aiding in the early detection of any retinal changes that may occur during treatment.

Regular Follow-up Eye Examinations

R - Retouch
R - Retouch

After the initial eye examination, regular follow-up exams are crucial. The AAO recommends the following schedule:

  • Every 6 months for the first year of treatment
  • Annually thereafter, provided there are no signs of retinal toxicity

However, if retinal changes are detected, more frequent examinations may be necessary. It's essential to communicate these recommendations clearly to patients, ensuring they understand the importance of adhering to the suggested eye exam schedule.

A - Analyse
A - Analyse

Factors Affecting Eye Exam Frequency

Several factors can influence the frequency of eye examinations for patients taking hydroxychloroquine. These include:

S - Source
S - Source

Cumulative Dose: The longer a patient takes hydroxychloroquine, the higher the risk of retinal toxicity. Therefore, the frequency of eye examinations may need to increase with prolonged use.

Daily Dose: Higher daily doses of hydroxychloroquine are associated with a greater risk of retinal toxicity. Patients taking higher doses may require more frequent eye examinations.

Age: Older patients may have a higher risk of retinal toxicity and may need more frequent eye examinations.

Pre-existing Eye Conditions: Patients with pre-existing eye conditions, such as retinal disease or macular degeneration, may require more frequent eye examinations while taking hydroxychloroquine.

In conclusion, regular eye examinations are vital for patients taking hydroxychloroquine to monitor and manage potential retinal toxicity. The frequency of these examinations should be guided by professional recommendations, considering individual patient factors. As healthcare providers, it's our responsibility to ensure patients are well-informed about the importance of adhering to the recommended eye exam schedule. By doing so, we can help minimize the risk of vision loss associated with hydroxychloroquine use.